Etanercept in the treatment of adult patients with Still's disease. - sprookjes - yvandenbroek - TriplyDB

Etanercept in the treatment of adult patients with Still's disease.

Etanercept in the treatment of adult patients with Still's disease.

http://www.wikidata.org/entity/Q40578875

about

Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor alpha blockers can make sense.Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients.Treatment of adult-onset Still's disease: a review Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases.Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study.Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004.Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005 Diagnosis and management of adult onset Still's disease.Pharmacoeconomic study of patients with chronic inflammatory joint disease before and during infliximab treatment.Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006.Adult Onset Still's Disease and Autoinflammation.Etanercept: an introduction.Biologic treatments for adult-onset Still's disease.Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options.Adult Onset Still's Disease: A Review on Diagnostic Workup and Treatment Options.Macrophage Activation Syndrome Associated with Adult-Onset Still's Disease Successfully Treated with Anakinra.Severe hyperferritinemia--a clue for severe hepatitis in a patient with adult-onset Still's disease.Tocilizumab for the treatment of adult-onset Still's disease: results from a case series.[Adult onset Still's disease, fever, diagnosis and therapy].Tocilizumab in refractory adult Still's disease.Successful treatment of a patient with refractory adult Still's disease by tacrolimus.Decrease of proteinuria in a patient with adult-onset Still's disease and glomerulonephritis after anti-TNFalpha therapy.Urticaria as a cutaneous sign of adult-onset Still's disease.Efficacy and safety of biological agents in adult-onset Still's disease.Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.Adult-onset Still's disease revealed by perimyocarditis and a concomitant reactivation of an EBV infection.A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still's Disease.A case of refractory adult-onset Still's disease treated with anakinra.Therapeutic responses and prognosis in adult-onset Still's disease.Cyclosporin A treatment for Japanese patients with severe adult-onset Still's disease.Biologic drugs in adult onset Still's disease: a systematic review and meta-analysis of observational studies.Is anti-TNF switching in refractory Still's disease safe and effective?Adult-onset Still's disease with macrophage activation syndrome successfully treated with a combination of methotrexate and etanercept.Diagnostic and management of life-threatening Adult-Onset Still Disease: a French nationwide multicenter study and systematic literature review.

P2860

Q30885007-8C389965-DEDD-4224-BC89-18392DF48295 Q33414045-A73CB27E-0B14-4121-8174-6D049B2687DE Q34043097-A632AC82-0F91-4372-BE02-F24D83516F75 Q35555229-0C3C1591-DC85-48C8-A411-BCD375ACC748 Q35557906-010218DB-0C7F-4C16-808E-9DB5E6E93D22 Q35579352-E79D2913-CEC5-43B5-AE61-AA294CCF85F7 Q35579517-4F73CCBF-1333-4BEE-9C32-787598D1BF8A Q35637158-A44FD9D5-F3B5-44A2-BFEF-85CE11E8AD49 Q35637390-0E9FAB04-F885-4DAB-9DA2-5621B69B877E Q35638252-61175FD6-4CE1-4802-BE93-CE1630951199 Q36220940-F7DB8783-E6EC-4E1B-8839-F8287D637303 Q37754607-26757487-A8F5-42A8-800D-E665D560C364 Q38122317-F3873F8C-2C23-4828-8AA4-3A17C91EE9DE Q38329024-C36862C2-B61E-4432-9582-AAA08F2CB1E3 Q38797433-15F84533-8BBA-4122-801A-6259216B55D0 Q40081000-DB0BAC1A-5D30-4F63-9405-6D32B91EB04D Q40182074-A6673E4E-DD98-4163-A725-D9933EE6A0F5 Q40235629-80DC5953-6116-462C-9F1C-DE81C369DB9C Q40289383-79ADAF59-BE72-464E-B6B0-233D9B6E8957 Q40350291-B38CFD4B-2D66-466A-B2D4-881B08967110 Q40452510-A41D1166-05CD-4577-AE7E-97CFB17D5C1C Q40455994-3ED05E15-146B-4339-AB37-7B765062CAD5 Q40459571-FACB9521-7FB7-4704-8978-5BFEDE147811 Q41472240-39529A32-0197-4643-98D4-20A6F5F66307 Q42226048-9183EA79-61AE-4838-8EEB-EFB389AE6914 Q42265969-48484597-B54B-48C9-ABD8-56CC6F8E4856 Q42677427-D92AD8EB-CC32-464A-A2A2-1C1C7328CC3F Q42939560-EE65A1D2-1A8D-404E-8365-B2582B61C9A7 Q43648042-18964768-582E-4652-A210-D81977610F99 Q44256196-7C3DAFF2-504A-44EA-89B7-FE22697E8FFB Q50224636-70DEA444-14C7-45A9-B21F-B3074956CE09 Q51042461-BFBFA999-0915-453E-A89D-B477219D6BBE Q51450723-9D7F4EA5-5B6E-4504-BA49-176F61701C8D Q55109011-B3342333-75EC-4C91-9B84-62A074F48A7F

P2860

Etanercept in the treatment of adult patients with Still's disease.

http://www.wikidata.org/entity/Q40578875

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Etanercept in the treatment of adult patients with Still's disease.

@en

type

label

Etanercept in the treatment of adult patients with Still's disease.

@en

prefLabel

Etanercept in the treatment of adult patients with Still's disease.

@en

P1433

Q40578875-4778681F-F1B3-43A5-8A00-829DD21FEC99

P1476

Q40578875-1EB36CAA-5D86-470F-8AD2-EA28A85A557A

P2093

Q40578875-212A923E-9D7F-4480-93F5-63C35740EA40

Q40578875-5937B5EE-36DB-4A7B-8A8E-C7D68ECE2C6B

Q40578875-7D333DF6-D0F9-406B-A441-87E83A63B1CB

Q40578875-95C129F7-6C3F-481F-9C37-7DF4B92A742D

Q40578875-980CB8CA-6C19-44DE-A9CB-1926643473FA

Q40578875-CBCA023E-93D9-4D5D-B79E-214FB7F8A1A3

Q40578875-ECB05858-BE37-4E89-AAC2-F87696847BE1

P2860

Q40578875-0B4D4D50-A692-4EC6-80C7-00BBC0E8999C

Q40578875-12A474A5-F48D-4BD5-B6FD-154C3B11BBD7

Q40578875-15F99B04-67F4-48F4-82F5-97CAEA517F52

Q40578875-15FF83B4-7A25-4A31-9CE3-EBA2D39C3B73

Q40578875-2B9E9219-DB99-4428-A21E-A8BC45B9A37C

Q40578875-42F492A7-A549-494F-AAAA-0C61E0C5BE7E

Q40578875-5790033D-AF83-4D6C-9F9D-25A147496056

Q40578875-6D3D0707-CD58-4634-8ED1-8B71FE05361C

Q40578875-86DC844A-9DA7-4DE6-AFDF-DBF16B88C3FD

Q40578875-B1B73B9B-BCFD-4B7C-90C8-ED5312134552

P304

Q40578875-2D2BBB88-E518-4DDD-BA3B-DFE7A3F8DF13

P31

Q40578875-CF286375-5E8A-4561-AB80-ABFC6C8A7105

P356

Q40578875-406177A6-D9C2-4333-A2B6-03E0ED7846BF

P433

Q40578875-6709E58F-8D35-40D8-B2C1-CBF07E532558

P478

Q40578875-A4A737DB-38A3-4108-849B-9F55BCFDF6EB

P577

Q40578875-CD044119-FF37-43B6-9080-2CF564412A62

P5875

Q40578875-24CDE305-C62A-4D90-A406-4AC561B4B5CB

P698

Q40578875-47274C41-AE2F-47B0-9832-034CE15C1CD2

P356

P1433

Arthritis & Rheumatology

P1476

Etanercept in the treatment of adult patients with Still's disease.

@en

P2093

Agnes L Maier

http://www.w3.org/2001/XMLSchema#string

Ellen M Gravallese

http://www.w3.org/2001/XMLSchema#string

M Elaine Husni

http://www.w3.org/2001/XMLSchema#string

Michael E Weinblatt

http://www.w3.org/2001/XMLSchema#string

Patricia Fraser

http://www.w3.org/2001/XMLSchema#string

Philip J Mease

http://www.w3.org/2001/XMLSchema#string

Steven S Overman

http://www.w3.org/2001/XMLSchema#string

P2860

Still's disease in the adult

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France.

Adult-onset Still's disease. Clinical course and outcome.

Suppression of fever and the acute-phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumour necrosis factor-alpha (cA2).

Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease.

Adult-onset Still's disease. Twenty-year followup and further studies of patients with active disease.

Adult Still's disease.

Comparison of long term evolution of adult onset and juvenile onset Still's disease, both followed up for more than 10 years.

P304

1171-1176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.10231

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11263929

http://www.w3.org/2001/XMLSchema#string

P698

12115220

http://www.w3.org/2001/XMLSchema#string